Last updated at 02 Jul 2024 05:42 PM
Director
DIN: 09208552
Arnav Gulati is currently associated with 2 companies in various capacities such as Individual Promoter, Director and Additional Director. They serve as a Director at HERBS & HEALTH BIOTECH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09208552.Arnav Gulati is currently involved in 3 different roles. Their most recent position is with NURTURE AQUA TECHNOLOGY PRIVATE LIMITED as a Additional Director. The first company Arnav Gulati was appointed to as a director was HERBS & HEALTH BIOTECH PRIVATE LIMITED. Arnav Gulati is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Arnav Gulati is currently associated with 2 companies in various capacities such as Individual Promoter, Director and Additional Director. They serve as a Director at HERBS & HEALTH BIOTECH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09208552.Arnav Gulati is currently involved in 3 different roles. Their most recent position is with NURTURE AQUA TECHNOLOGY PRIVATE LIMITED as a Additional Director. The first company Arnav Gulati was appointed to as a director was HERBS & HEALTH BIOTECH PRIVATE LIMITED. Arnav Gulati is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| HERBS & HEALTH BIOTECH PRIVATE LIMITED | Individual Promoter | 18-Jun-2021 |
| HERBS & HEALTH BIOTECH PRIVATE LIMITED | Director | 18-Jun-2021 |
| NURTURE AQUA TECHNOLOGY PRIVATE LIMITED | Additional Director | 05-Nov-2021 |